Savara (SVRA) Assets Average (2011 - 2026)
Savara (SVRA) reported Assets Average of $237.5 million for Q1 2026, up 18.12% year-over-year from $201.1 million in Q1 2025, and up 20.47% quarter-over-quarter from $197.2 million in Q4 2025.
Savara (SVRA) Assets Average (2011 - 2026) Analysis & Trends
Savara (SVRA) has 16 years of Assets Average data on file, last reported at $237.5 million in Q1 2026.
- Assets Average for Q1 2026 came in at $237.5 million, up 18.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $237.5 million (up 18.12% YoY), and the FY2025 annual result was $233.2 million, up 19.43% from the prior year.
- Assets Average climbed to $237.5 million in Q1 2026 per SVRA's latest filing, from $197.2 million in the prior quarter.
- Over five years, Assets Average peaked at $237.5 million in Q1 2026 and troughed at $124.6 million in Q2 2023.
- A 5-year average of $171.5 million and a median of $167.9 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2023 and 2024: Assets Average dropped 22.85% in 2023, then climbed 25.6% in 2024.
- A 5-year view of Assets Average shows it stood at $143.8 million in 2022, then gained by 25.08% to $179.8 million in 2023, then climbed by 25.6% to $225.8 million in 2024, then declined by 12.69% to $197.2 million in 2025, then gained by 20.47% to $237.5 million in 2026.
- Business Quant data shows SVRA's Assets Average at $237.5 million in Q1 2026, $197.2 million in Q4 2025, and $152.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | 237.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 237.54 Mn |
| Dec 31, 2025 | 197.18 Mn |
| Sep 30, 2025 | 152.34 Mn |
| Jun 30, 2025 | 176.54 Mn |
| Mar 31, 2025 | 201.10 Mn |
| Dec 31, 2024 | 225.85 Mn |
| Sep 30, 2024 | 189.24 Mn |
| Jun 30, 2024 | 148.98 Mn |
| Mar 31, 2024 | 167.93 Mn |
| Dec 31, 2023 | 179.82 Mn |
| Sep 30, 2023 | 150.95 Mn |
| Jun 30, 2023 | 124.60 Mn |
| Mar 31, 2023 | 134.57 Mn |
| Dec 31, 2022 | 143.77 Mn |
| Sep 30, 2022 | 152.27 Mn |
| Jun 30, 2022 | 161.49 Mn |
| Mar 31, 2022 | 171.40 Mn |
| Dec 31, 2021 | 181.94 Mn |
| Sep 30, 2021 | 191.85 Mn |
| Jun 30, 2021 | 202.03 Mn |